Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities

J E Coia; J A Wilson; A Bak; G L Marsden; M Shimonovich; H P Loveday; H Humphreys; N Wigglesworth; A Demirjian; J Brooks; L Butcher; J R Price; L Ritchie; W Newsholme; D A Enoch; J Bostock; M Cann; A P R Wilson

doi:10.1016/j.jhin.2021.09.022

Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities

J Hosp Infect. 2021 Dec:118S:S1-S39. doi: 10.1016/j.jhin.2021.09.022. Epub 2021 Oct 29.

Authors

J E Coia¹, J A Wilson², A Bak³, G L Marsden⁴, M Shimonovich⁵, H P Loveday², H Humphreys⁶, N Wigglesworth⁷, A Demirjian⁸, J Brooks⁹, L Butcher¹⁰, J R Price¹¹, L Ritchie¹², W Newsholme¹³, D A Enoch¹⁴, J Bostock¹⁵, M Cann¹⁶, A P R Wilson¹⁷

Affiliations

¹ Department of Clinical Microbiology, Hospital South West Jutland, Esbjerg, Denmark; Department of Regional Health Research IRS, University of Southern Denmark, Denmark; Healthcare Infection Society, London, UK.
² Richard Wells Research Centre, University of West London, London, UK; Infection Prevention Society, Seafield, UK.
³ Healthcare Infection Society, London, UK. Electronic address: aggie.bak@his.org.uk.
⁴ Healthcare Infection Society, London, UK.
⁵ Healthcare Infection Society, London, UK; MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
⁶ Healthcare Infection Society, London, UK; Department of Clinical Microbiology, The Royal College of Surgeons, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
⁷ Infection Prevention Society, Seafield, UK; East Kent Hospitals University, NHS Foundation Trust, Canterbury, UK.
⁸ Healthcare-associated Infection and Antimicrobial Resistance, Public Health England, London, UK; Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.
⁹ Infection Prevention Society, Seafield, UK; University Hospital Southampton NHS Foundation Trust, UK.
¹⁰ Infection Prevention Society, Seafield, UK; Oxford University Hospitals NHS Foundation Trust, UK.
¹¹ Healthcare Infection Society, London, UK; Imperial College Healthcare NHS Trust, London, UK.
¹² Healthcare Infection Society, London, UK; NHS England and NHS Improvement, London, UK.
¹³ Healthcare Infection Society, London, UK; Guy's and St Thomas' NHS Foundation Trust, UK.
¹⁴ Healthcare Infection Society, London, UK; Clinical Microbiology & Public Health Laboratory, Public Health England, Addenbrooke's Hospital, Cambridge, UK.
¹⁵ Lay Member, UK.
¹⁶ Lay Member, UK; MRSA Action UK, Preston, UK.
¹⁷ Healthcare Infection Society, London, UK; University College London Hospitals NHS Foundation Trust, UK. Electronic address: peter.wilson9@nhs.net.

PMID: 34757174
DOI: 10.1016/j.jhin.2021.09.022

No abstract available

Keywords: Cross infection; Decontamination; Disease reservoirs; Handwashing; Infection control; Methicillin resistance; Meticillin; Microbial drug resistance; Population surveillance; Staphylococcus aureus; Vancomycin resistance.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Cross Infection* / drug therapy
Cross Infection* / epidemiology
Cross Infection* / prevention & control
Delivery of Health Care
Humans
Methicillin
Methicillin Resistance
Methicillin-Resistant Staphylococcus aureus*
Microbial Sensitivity Tests
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / epidemiology
Staphylococcal Infections* / prevention & control

Substances

Anti-Bacterial Agents
Methicillin